REPH going to run. > FDA phase II results. Recro Pharma Plans to Meet With FDA to Discuss Phase III Plans *Friday 07/17/2015 08:02 AM ET - Dow Jones News
Recro Pharma: Dex-IN Met Primary Endpoint of Phase II Clinical Trial *Friday 07/17/2015 08:02 AM ET - Dow Jones News
Recro Pharma Announces Positive Top-Line Results For Phase II Clinical Trial Of Dex-IN *Friday 07/17/2015 08:00 AM ET - Dow Jones News View more recent headlines
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.